HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Jürgens Selected Research

H Jürgens Research Topics

Disease

21Neoplasms (Cancer)
02/2012 - 09/2000
12Ewing Sarcoma (Sarcoma, Ewing)
09/2021 - 10/2000
6Osteosarcoma (Osteogenic Sarcoma)
05/2007 - 11/2000
6Sarcoma (Soft Tissue Sarcoma)
05/2007 - 11/2000
5Neoplasm Metastasis (Metastasis)
03/2010 - 09/2000
3Medulloblastoma
05/2007 - 07/2001
3Necrosis
03/2001 - 10/2000
2Ototoxicity
02/2008 - 09/2000
2Hearing Loss (Hearing Impairment)
02/2008 - 09/2000
2Lymphoma (Lymphomas)
02/2005 - 01/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2004 - 05/2001
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2004 - 04/2001
1Hodgkin Disease (Hodgkin's Disease)
10/2012
1Aplastic Anemia (Anemia, Hypoplastic)
12/2007
1Brain Neoplasms (Brain Tumor)
05/2007
1Ependymoma
05/2007
1Cardiomyopathies (Cardiomyopathy)
04/2006
1Residual Neoplasm
04/2005
1Hypotension (Low Blood Pressure)
06/2004
1Anaphylaxis (Anaphylactic Shock)
06/2004
1Malignant Fibrous Histiocytoma
11/2003
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2003
1Graft vs Host Disease (Graft-Versus-Host Disease)
07/2002
1Fanconi Anemia (Fanconi's Anemia)
07/2002
1Neutropenia
12/2001
1Pain (Aches)
12/2001
1Body Weight (Weight, Body)
12/2001
1Disease Progression
12/2001
1Invasive Fungal Infections
12/2001
1Second Primary Neoplasms (Neoplasms, Second)
11/2001
1Hemolysis
08/2001
1Hemolytic Anemia
08/2001
1Mitochondrial Diseases (Mitochondrial Disease)
10/2000
1Leukemia
01/2000
1Febrile Neutropenia
01/2000

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
02/2008 - 09/2000
2HLA Antigens (Human Leukocyte Antigens)IBA
10/2012 - 07/2011
2hydrogen sulfite (bisulfite)IBA
05/2007 - 02/2006
2Fluorine-18IBA
02/2005 - 09/2000
2Gemtuzumab (Mylotarg)FDA Link
06/2004 - 02/2003
1C-Reactive ProteinIBA
10/2012
1Low Density Lipoprotein Receptor-Related Protein-2IBA
02/2008
1Cyclin-Dependent Kinase Inhibitor p16IBA
05/2007
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
05/2007
1IfosfamideFDA LinkGeneric
04/2007
1Carboplatin (JM8)FDA LinkGeneric
02/2007
1Antineoplastic Agents (Antineoplastics)IBA
04/2006
1AnthracyclinesIBA
04/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2006
1theasinensin AIBA
02/2006
1trichostatin A (A 300)IBA
02/2006
1DecitabineFDA Link
02/2006
1Glucose (Dextrose)FDA LinkGeneric
02/2005
1CatecholaminesIBA
06/2004
1PlatinumIBA
05/2004
1CalicheamicinsIBA
02/2003
1IsotopesIBA
02/2002
1Technetium Tc 99m MedronateIBA
01/2002
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2002
1FluorineIBA
01/2002
1liposomal amphotericin BFDA Link
12/2001
1samarium Sm-153 lexidronam (Quadramet)FDA Link
12/2001
1Etoposide (VP 16)FDA LinkGeneric
11/2001
1Vincristine (Oncovin)FDA LinkGeneric
11/2001
1Alkylating AgentsIBA
11/2001
1Topoisomerase InhibitorsIBA
11/2001
1Rituximab (Mabthera)FDA Link
08/2001
1DNA (Deoxyribonucleic Acid)IBA
07/2001
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
05/2001
1Daunorubicin (Cerubidine)FDA LinkGeneric
05/2001
1Mitoxantrone (Novantrone)FDA LinkGeneric
05/2001
1Cytarabine (Cytosar-U)FDA LinkGeneric
05/2001
1GadoliniumIBA
03/2001
1Cytostatic AgentsIBA
01/2001
1beta-Aminoethyl Isothiourea (AET)IBA
11/2000
1LigandsIBA
10/2000
1Caspase 8 (Caspase-8)IBA
10/2000
1methylene diphosphonateIBA
09/2000
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2000

Therapy/Procedure

15Drug Therapy (Chemotherapy)
10/2012 - 10/2000
15Therapeutics
02/2008 - 09/2000
5Stem Cell Transplantation
09/2021 - 11/2000
4Radiotherapy
05/2007 - 01/2001
3Transplantation
12/2007 - 03/2001
3Neoadjuvant Therapy
05/2004 - 11/2000
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2007 - 03/2003
2Craniospinal Irradiation
04/2005 - 05/2004
1Limb Salvage
03/2006
1Aftercare (After-Treatment)
03/2006
1Critical Care (Surgical Intensive Care)
06/2004
1Hematopoietic Stem Cell Transplantation
03/2003
1Chemoradiotherapy
02/2002
1Combination Drug Therapy (Combination Chemotherapy)
12/2001
1Erythrocyte Transfusion
08/2001
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
08/2001
1Immunotherapy
08/2001
1Combined Modality Therapy
04/2001
1Second-Look Surgery
04/2001
1Intravenous Injections
03/2001